163 related articles for article (PubMed ID: 8252208)
1. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate.
Jiang FN; Liu DJ; Neyndorff H; Chester M; Jiang SY; Levy JG
J Natl Cancer Inst; 1991 Sep; 83(17):1218-25. PubMed ID: 1870147
[TBL] [Abstract][Full Text] [Related]
3. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative.
Marcus J; Glassberg E; Dimino-Emme L; Yamamoto R; Moy RL; Vari SG; Papaioannou T; Pergadia VR; Snyder WJ; Grundfest WS
J Dermatol Surg Oncol; 1994 Jun; 20(6):375-82. PubMed ID: 8014262
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
Andrejevic Blant S; Ballini JP; van den Bergh H; Fontolliet C; Wagnières G; Monnier P
Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors.
Schmidt MH; Reichert KW; Ozker K; Meyer GA; Donohoe DL; Bajic DM; Whelan NT; Whelan HT
Pediatr Neurosurg; 1999 May; 30(5):225-31. PubMed ID: 10461068
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
8. Verdins in photodynamic therapy of squamous cell carcinoma.
Hayden RE; McLear PW; Morgan AR; Bischoff JK
Am J Otolaryngol; 1990; 11(2):125-30. PubMed ID: 2343995
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update.
Lui H
Semin Oncol; 1994 Dec; 21(6 Suppl 15):11-4. PubMed ID: 7992101
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice.
Jiang FN; Richter AM; Jain AK; Levy JG; Smits C
Biotechnol Ther; 1993; 4(1-2):43-61. PubMed ID: 8374512
[TBL] [Abstract][Full Text] [Related]
12. Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents.
Davis N; Liu D; Jain AK; Jiang SY; Jiang F; Richter A; Levy JG
Photochem Photobiol; 1993 Apr; 57(4):641-7. PubMed ID: 8506392
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for premalignant lesions in DMBA-treated hamsters: a preliminary study.
Kingsbury JS; Cecere W; Mang TS; Liebow C
J Oral Maxillofac Surg; 1997 Apr; 55(4):376-81; discussion 381-2. PubMed ID: 9120701
[TBL] [Abstract][Full Text] [Related]
14. The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.
Yang PW; Hung MC; Hsieh CY; Tung EC; Wang YH; Tsai JC; Lee JM
Lasers Med Sci; 2013 Feb; 28(2):605-14. PubMed ID: 22585382
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model.
Dube A; Sharma S; Gupta PK
Oral Oncol; 2006 Jan; 42(1):77-82. PubMed ID: 16140565
[TBL] [Abstract][Full Text] [Related]
17. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
Fingar VH; Kik PK; Haydon PS; Cerrito PB; Tseng M; Abang E; Wieman TJ
Br J Cancer; 1999 Apr; 79(11-12):1702-8. PubMed ID: 10206280
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.
Soukos NS; Hamblin MR; Keel S; Fabian RL; Deutsch TF; Hasan T
Cancer Res; 2001 Jun; 61(11):4490-6. PubMed ID: 11389080
[TBL] [Abstract][Full Text] [Related]
19. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
Richter AM; Waterfield E; Jain AK; Allison B; Sternberg ED; Dolphin D; Levy JG
Br J Cancer; 1991 Jan; 63(1):87-93. PubMed ID: 1989669
[TBL] [Abstract][Full Text] [Related]
20. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.
Busetti A; Soncin M; Jori G; Rodgers MA
Br J Cancer; 1999 Feb; 79(5-6):821-4. PubMed ID: 10070875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
